Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Envista Holdings CorpNYSE: NVST
Net Income · Q3 FY2026 · quarter ended Oct 2026
Net income turns positive
Q3 FY2026 net income was $469.6M, compared with -$30.3M a year earlier. Trailing-twelve-month net income was $633.6M. Over 3 fiscal years it compounded at -42.2% a year.
Context
- Net income amounted to 1.7% of revenue in FY2025, down 42.8 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 11 analysts of $264M (+461.7%) for the fiscal year ending Dec 2026, a step up from the +104.2% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- $469.6M+408.2% QoQ
- Last fiscal yearDec 2025
- $47M+104.2% YoY
- LTMOct 2026
- $633.6M+4041.2% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 47M USD
- Year-over-year change
- +104.2%
- 4-year CAGR
- -39.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47M | +104.2% |
| FY2024 | 2024-12-31 | (1.12B) | -1016.4% |
| FY2023 | 2023-12-31 | (100.2M) | -141.2% |
| FY2022 | 2022-12-31 | 243.1M | -28.6% |
| FY2021 | 2021-12-31 | 340.5M | — |
Net Income vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 net income of $633.6M is the largest of the 11 companies compared; the peer median is $219.35M.
- Its year-over-year change of +4041.2% is the highest of 11, against a peer median of +24.8%.
- Net income amounts to 22.0% of revenue for NVST, versus a peer median of 13.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $633.6M | +4041.2% | -42.2% | 22.0% | |
| LTM Mar 2026 | $627M | -30.9% | -14.3% | 17.0% | |
| LTM Mar 2026 | $608.92M | +10.8% | -6.7% | 91.0% | |
| LTM Jun 2026 | $519.41M | +25.8% | +38.5% | — | |
| LTM Jun 2026 | $391.59M | -11.6% | -57.7% | 236.9% | |
| LTM Jun 2026 | $294.37M | +23.9% | +86.0% | — | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $226.7M | +45.1% | +0.1% | 9.7% |
| LTM Jun 2026 | $144.33M | -323.8% | — | 17.4% | |
| LTM Jun 2026 | $30.09M | +181.4% | — | 1.4% | |
| LTM Jun 2026 | $28.12M | +71.4% | — | 1.2% | |
| LTM Mar 2026 | $19.79M | +121.8% | -83.1% | 0.5% | |
| Peer median (excluding NVST) | $219.35M | +24.8% | -6.7% | 13.4% | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| Deferred Income Tax | 0 | 0 | (37M) | (29M) | 11.4M |
| Stock-Based Compensation | 28.2M | 30.5M | 30.7M | 35.3M | 37.6M |
| Change in Working Capital | (203.2M) | (271.7M) | (108.4M) | 97.4M | 8.9M |
| Accounts Receivables | (43.2M) | (71M) | (17M) | 10M | (48.5M) |
| Inventory | (66M) | (39.9M) | 35.1M | 3.6M | (29.1M) |
| Accounts Payables | (20.3M) | 44.5M | (46.3M) | (1.2M) | 7.5M |
| Other Working Capital | (73.7M) | (205.3M) | (80.2M) | 85M | 79M |
| Other Non-Cash Items | 44.2M | 18.7M | 328M | 1.23B | 54.8M |
| Operating Cash Flow | 361.6M | 182.7M | 275.7M | 336.5M | 275.7M |
| Capital Expenditures | (54.7M) | (75.7M) | (58.2M) | (33.8M) | (45.3M) |
| Acquisitions (Net) | 310.4M | (622.3M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (32.8M) | (9.9M) |
| Sales of Investments | 11.4M | 56M | 10.7M | 9.7M | 10.4M |
| Other Investing Activities | (4.4M) | (15.3M) | (14.9M) | 2.3M | (6.3M) |
| Investing Cash Flow | 262.7M | (657.3M) | (62.4M) | (54.6M) | (51.1M) |
| Debt Repayment | (475.7M) | (200K) | 115.4M | (100M) | (900K) |
| Common Stock Issued | 19.5M | 21.8M | 11.3M | 2.4M | 2.8M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (166.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.4M) | (9.1M) | (7.8M) | (6.1M) | (6.2M) |
| Financing Cash Flow | (465.6M) | 12.5M | 118.9M | (103.7M) | (170.9M) |
| Effect of Forex Changes | 26M | (4.6M) | 900K | (49.1M) | 88.9M |
| Net Change in Cash | 184.7M | (466.7M) | 333.1M | 129.1M | 142.6M |
| Free Cash Flow | 306.9M | 107M | 217.5M | 302.7M | 230.4M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.